Replication data for: Selection in Health Insurance Markets and Its Policy Remedies
Principal Investigator(s): View help for Principal Investigator(s) Michael Geruso; Timothy J. Layton
Version: View help for Version V1
Name | File Type | Size | Last Modified |
---|---|---|---|
Replication | 10/12/2019 06:37:PM | ||
LICENSE.txt | text/plain | 14.6 KB | 10/12/2019 02:37:PM |
Project Citation:
Geruso, Michael, and Layton, Timothy J. Replication data for: Selection in Health Insurance Markets and Its Policy Remedies. Nashville, TN: American Economic Association [publisher], 2017. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-10-12. https://doi.org/10.3886/E114003V1
Project Description
Summary:
View help for Summary
Selection (adverse or advantageous) is the central problem that inhibits the smooth, efficient functioning of competitive health insurance markets. Even—and perhaps especially—when consumers are well-informed decision makers and insurance markets are highly competitive and offer choice, such markets may function inefficiently due to risk selection. Selection can cause markets to unravel with skyrocketing premiums and can cause consumers to be under- or overinsured. In its simplest form, adverse selection arises due to the tendency of those who expect to incur high health care costs in the future to be the most motivated purchasers. The costlier enrollees are more likely to become insured rather than to remain uninsured, and conditional on having health insurance, the costlier enrollees sort themselves to the more generous plans in the choice set. These dual problems represent the primary concerns for policymakers designing regulations for health insurance markets. In this essay, we review the theory and evidence concerning selection in competitive health insurance markets and discuss the common policy tools used to address the problems it creates. We emphasize the two markets that seem especially likely to be targets of reform in the short and medium term: Medicare Advantage (the private plan option available under Medicare) and the state-level individual insurance markets.
Scope of Project
JEL Classification:
View help for JEL Classification
D82 Asymmetric and Private Information; Mechanism Design
G22 Insurance; Insurance Companies; Actuarial Studies
H51 National Government Expenditures and Health
I13 Health Insurance, Public and Private
I18 Health: Government Policy; Regulation; Public Health
D82 Asymmetric and Private Information; Mechanism Design
G22 Insurance; Insurance Companies; Actuarial Studies
H51 National Government Expenditures and Health
I13 Health Insurance, Public and Private
I18 Health: Government Policy; Regulation; Public Health
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.